Abstract
Background
Endogenous hydrogen sulfide (H2S) is increasingly being recognized as an important gaseous physiological mediator. Accumulating evidence shows the functions of H2S in various models of disease, but rarely in colitis. In this study, we investigated the role of endogenous H2S in a dextran sodium sulfate (DSS)-induced colitis model.
Methods
Acute colitis was induced using 8% DSS in male BALB/c mice. The mRNA expression of cystathionine γ-lyase (CSE), the primary synthetase of H2S in the gastrointestinal tract, and cystathionine-β-synthetase (CBS) was measured by real-time RT-PCR. The amount of H2S in the colonic mucosa was measured by gas chromatography. Colitis severity was evaluated clinically, histologically, and biochemically under the condition of co-treatment with DL-propargylglycine (PAG), an irreversible CSE inhibitor, and sodium sulfide (Na2S), an H2S donor.
Results
The mRNA expression levels of CSE and CBS, and the H2S content in the colonic mucosa were increased with time after DSS administration. The disease activity index, which was determined by weight loss, stool consistency, and intestinal bleeding, increased after DSS administration. PAG significantly enhanced the increase in the disease activity index scores. PAG also significantly increased tissue-associated myeloperoxidase activity and thiobarbituric acid-reactive substances in the inflamed mucosa. Moreover, Na2S counteracted these effects of PAG.
Conclusions
Taken together, the results indicated that the inhibition of endogenous H2S generation caused the deterioration of DSS-induced colitis. We conclude that physiological H2S might act as an anti-inflammatory molecule in colitis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hydrogen sulfide (H2S) is a colorless, water-soluble gas with the unpleasant smell of rotten eggs. Like nitric oxide (NO) and carbon monoxide (CO), H2S has been recognized not only as a pollutant but also as an important gaseous physiological mediator [1]. H2S is synthesized endogenously from l-cysteine in various mammalian tissues by two enzymes: cystathionine-β-synthetase (CBS) and cystathionine-γ-lyase (CSE). CBS is the predominant enzyme in brain, nervous system, liver, and kidney. CSE is expressed mainly in liver and in both vascular and nonvascular smooth muscles. Low levels of CSE are also detectable in the gastrointestinal tract of rodents [2]. It has been reported that H2S mediates vasodilation and analgesic action by opening K +ATP channels [2]. The involvement of H2S in inflammation has been studied in various disease models. Evidence is accumulating to show that H2S exerts anti-inflammatory effects at low concentrations [3–7], whereas some papers demonstrate the pro-inflammatory effects of H2S [8–13]. H2S can upregulate anti-inflammatory genes such as heme oxygenase-1 [14, 15], which leads to the production of CO, another anti-inflammatory gaseous mediator [16–19]. Furthermore, low levels of H2S can upregulate the endogenous antioxidant systems [20] and can neutralize reactive species [21].
The aim of this study is to elucidate the involvement of H2S in colitis, and to provide new insights into the pathogenesis of inflammatory bowel disease and into therapeutic approaches to it. We examined the change in the expression levels of H2S-generating enzymes and the amount of H2S in the inflamed colonic mucosa of mice. The effects of a donor and an inhibitor of H2S on colitis and oxidative stress were also investigated.
Materials and Methods
Chemicals
All chemicals were prepared immediately before use. DL-propargylglycine and sodium sulfide were obtained from Sigma-Aldrich (St. Louis, MO, USA). Thiobarbituric acid (TBA) and 3,3′,5,5′-tetramethylbenzidine were obtained from Wako Pure Chemical (Osaka, Japan). 1,1,3,3-Tetramethoxy propane was obtained from Tokyo Kasei (Tokyo, Japan). All other chemicals were of reagent grade.
Experimental Procedures
Six-week-old male BALB/c mice weighing 18–20 g were purchased from Shimizu Experimental Animals (Osaka, Japan). The mice were caged individually in a room kept at 18–24°C with 40–70% relative humidity and a 12-h light/dark cycle. They were allowed free access to food and drinking water. The mice were fed rodent diet CE-2 (Nihon Clea, Tokyo, Japan) during their 1-week acclimatization. Then, acute colitis was induced by 8.0% (w/v) DSS (Wako Pure Chemical) solution in the drinking water for 7 days. The intake of DSS solution was monitored throughout the experiments and was found to be unchanged among the experimental groups. PAG and Na2S were dissolved in physiological saline. The mice were randomized into groups receiving either or both PAG (1, 10 mg/kg) and Na2S (1, 10 μmol/kg) or physiological saline only, by intraperitoneal injection on each of the 7 days. Body weight, stool consistency, and blood in stool of each mouse were assessed on days 0, 3, 5, and 7. The mice were then killed on day 7 and their colons were removed for macroscopic and histological examination. The colon was resected and measured between the ileocecal junction and the proximal rectum, close to its passage under the pelvisternum, and then the colonic mucosa was scraped off and used for biochemical assay and RNA isolation. The maintenance of the animals and the experimental procedures performed on them were carried out in accordance with National Institutes of Health (NIH) guidelines for the use of experimental animals. All procedures were approved by the Animal Care Committee of Kyoto Prefectural University of Medicine (Kyoto, Japan).
Real-Time RT-PCR for Cystathionine γ-Lyase (CSE) and Cystathionine-β-Synthetase (CBS)
Mice were killed after DSS administration for 0–7 days, and then colonic mucosa was collected and used for RNA isolation. The expression of mRNA for CSE and CBS was quantified by real-time PCR. Total cellular RNA was extracted by the acid guanidinium phenol chloroform method using an Isogen kit (Nippon Gene, Tokyo, Japan). The concentration of RNA was determined by absorbance at 260 nm in relation to absorbance at 280 nm. RNA was stored at −70°C until reverse transcription was performed. An aliquot (1 μg) of extract RNA was reverse-transcribed into first-strand cDNA at 42°C for 40 min, using 100 U/ml reverse transcriptase (Takara Biochemicals, Shiga, Japan) and 0.1 μM of oligo(dT)-adapter primer (Takara) in a 20-μl reaction mixture. Real-time PCR was carried out with a 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA) using the DNA-binding dye SYBER Green I for the detection of PCR products. The reaction mixture (RT-PCR kit, Code RRO43A; Takara) contained 12.5 μl Premix Ex Taq, 2.5 μl SYBER Green I, custom-synthesized primers, ROX reference dye, and cDNA (equivalent to 20 ng total RNA) to give a final reaction volume of 25 μl. The primers were as follows: for mouse cystathionine γ-lyase, sense primer 5′-GATGGCGGTGGCTCGTT-3′ and antisense primer 5′-GGTAGCCCAGGATAAACAACCTT-3′; for mouse cystathionine-β-synthetase, sense primer 5′-TGAACCAGACGGAGCAAACA-3′ and antisense primer 5′-CCAGGACTGTCGGGATGAAG-3′; and for β-actin, sense primer 5′-TGTCCACCTTCCAGCAGATGT-3′ and antisense primer 5′-AGCTCAGTAACAGTCCGCCTAGA-3′. The PCR settings were as follows: initial denaturation of 10 s at 95°C was followed by 40 cycles of amplification for 5 s at 95°C and 31 s at 60°C. The PCR products were quantified using standard DNA for each purified PCR product of the reverse-transcribed RNA. Relative expression was calculated as the density of the product of the respective target gene divided by that of β-actin from the same cDNA.
Measurement of H2S Content in the Colonic Mucosa
Mice were killed after DSS administration for 0–7 days. The amount of H2S in the colonic mucosa was measured by gas chromatography (Biogas H2S Analyzer BAS-3000; Mitleben R&D Associates, Osaka, Japan). Briefly, each homogenate of the colonic mucosa with 1 ml of saline was poured into a 10-ml vial with septum after vigorous stirring, and then 1,000 μl of pure water was added. H2S gas was released by adding 500 μl of 100% trichloroacetic acid into each vial with a syringe through the septum, and then incubated at 40°C for 30 min after vigorous stirring. Then, 500 µm of head space gas was removed from the reaction tube and applied to the BAS-3000 port.
Evaluation of Colitis Severity
The disease activity index (DAI) was determined by scoring changes in body weight, blood in stool, and stool consistency, as described previously [22]. Occult bleeding was tested using a commercial kit based on the detection of the peroxidase activity of heme in the stool (Occult Blood Slide 5 Shionogi; Shionogi & Co., Osaka, Japan). The DAI score has been shown to correlate well with histological measures of inflammatory and crypt damage. We used five grades of weight loss (0, no loss or weight gain; 1, 1–5% loss; 2, 5–10% loss; 3, 10–20% loss; 4, >20% loss), three grades of stool consistency (0, normal; 2, loose; and 4, diarrhea), and three grades of occult blood (0, normal; 2, occult blood-positive; and 4, gross bleeding). The combined scores were then divided by three to obtain the final DAI scores. The colon was placed on a nonabsorbent surface and measured with a ruler. The entire colon was divided into three segments (proximal, middle, and distal), and a part of each segment was fixed in 10% neutral buffered formalin. After fixation, the specimens were embedded in paraffin, divided into 7-μm sections, and stained with H&E stain.
Measurement of MPO Activity and TBA-Reactive Substances
Tissue-associated myeloperoxidase (MPO) activity was measured by an alternative method of Grisham et al. [23] as an index of neutrophil accumulation. Two milliliters of mucosal homogenate was centrifuged at 20,000 × g for 15 min at 4°C to pellet the insoluble cellular debris. The pellet was then rehomogenized in an equivalent volume of 0.05 mol potassium phosphate buffer (pH 5.4) containing 0.5% hexadecyltrimethylammonium bromide. The samples were centrifuged at 20,000 × g for 15 min at 4°C, and the supernatants were saved. MPO activity was assessed by measuring the H2O2-dependent oxidation of 3,3′,5,5′-tetramethylbenzidine. One unit of enzyme activity was defined as the amount of MPO that altered the absorbance for 1.0 min under the conditions of 655 nm and 25°C.
The concentration of thiobarbituric acid (TBA)-reactive substances in the colonic mucosa was measured using the method of Ohkawa et al. [24] as an index of lipid peroxidation. After the experiments, the colonic mucosa was collected and homogenized with 1.5 ml of 10 mmol/l potassium phosphate buffer (pH 7.8) containing 30 mmol/l KCl in a Teflon Potter–Elvehjem homogenizer. The level of TBA-reactive substances in the mucosal homogenates was expressed as nanomoles of malondialdehyde per milligram of protein using 1,1,3,3-tetramethoxypropane as the standard. Total protein in the tissue homogenates was measured by the method of Lowry [25].
Statistical Analysis
All data are presented as means ± SEM. Comparisons of groups of data were performed using one-way or two-way analysis of variance (ANOVA) followed by Bonferroni’s post-tests. All analyses were performed using GraphPad Prism 5.01 for Windows (GraphPad Software, La Jolla, CA, USA). A p value of less than 0.05 was considered significant.
Results
CSE, CBS mRNA Expression, and H2S Content in the Inflamed Mucosa
After DSS administration, mice presented with acute colitis including the symptoms of loose stool, melena, and severe weight loss.
The relative expression level of mRNA for CSE and CBS in the colonic mucosa increased from day to day after DSS administration. The CSE and CBS mRNA expression was significantly higher on day 7 than on day 0 (Fig. 1a). The expression level of CSE mRNA was more than 200 times larger than that of CBS mRNA on day 7.
The amount of H2S in the colonic mucosa significantly increased from 0.02797 ± 0.002292 nmol/mg tissue, a basal concentration, to 0.06468 ± 0.009493 nmol/mg tissue 7 days after DSS administration (Fig. 1b).
Effects of PAG and Na2S on DAI Scores, Colonic Length, and Histology
Colonic length decreased significantly after DSS administration for 7 days. The colons of the PAG (1, 10 mg/kg)-treated mice were significantly shorter than those of the vehicle-treated mice. The colon shortening after DSS administration was not affected by Na2S at either dose of 1 or 10 μmol/kg (Fig. 2).
DSS administration elevated the DAI scores day by day. The DAI scores were higher in the PAG-treated mice than in the vehicle-treated mice (significant on days 3, 5, and 7 at both 1 and 10 mg/kg of PAG). In contrast, the DAI scores were lower in the Na2S-treated mice than in the vehicle-treated mice (significant on day 7 at 10 μmol/kg of Na2S) (Fig. 3). Treatment with PAG or Na2S did not affect the DAI scores in sham mice (data not shown).
Therefore, we used PAG and Na2S at concentrations of 10 mg/kg and 10 μmol/kg, respectively, in the following experiments.
The DAI scores were significantly higher in the PAG-treated mice than in the vehicle-treated mice on day 7. The increase in the DAI scores by PAG was significantly counteracted by co-treatment with Na2S (Fig. 4).
Figure 5 shows typical histological appearances in the PAG-treated mice and in the PAG + Na2S-treated mice. Large areas of epithelial crypt loss, ulceration, and neutrophil infiltration throughout the colonic mucosa were observable in the colon of the vehicle-treated mice. PAG deteriorated these findings of colitis. In contrast, co-treatment with Na2S resulted in smaller erosions with fewer neutrophils.
Effects of PAG and Na2S on MPO Activity and TBA-Reactive Substances
Tissue-associated MPO activity in the colonic mucosa increased after DSS administration for 7 days. MPO activity was significantly higher in the PAG-treated mice (4.157 ± 1.564 mU/mg protein) than in the vehicle-treated mice (0.5966 ± 0.0819 mU/mg protein). MPO activity was significantly lower in the PAG + Na2S-treated mice (0.7013 ± 0.2756 mU/mg protein) than in the PAG-treated mice. The increase in MPO activity by PAG was negated by co-treatment with Na2S (Fig. 6a).
Levels of TBA-reactive substances, which serve as an index of lipid peroxidation, in the colonic mucosa 7 days after DSS administration were significantly higher in the PAG-treated mice (11.07 ± 2.129 nmol/mg protein) than in the vehicle-treated mice (5.285 ± 0.2810 nmol/mg protein). Levels of TBA-reactive substances were significantly lower in the PAG + Na2S-treated mice (5.342 ± 0.2871 nmol/mg protein) than in the PAG-treated mice. The increase in TBA-reactive substances by PAG was negated by co-treatment with Na2S (Fig. 6b).
Discussion
The present study showed that the mRNA expression levels of CSE and CBS, H2S-generating enzymes, and H2S content in the colonic mucosa increased with time after DSS administration. Both CSE and CBS mRNA expression were significantly elevated after development of colitis, however, the expression level of CSE mRNA was more than 200 times larger than that of CBS mRNA. These results suggest that CSE may operate as the primary synthetase of H2S in the colonic mucosa in this model. Several lines of evidence suggest that ulcerative colitis could be associated with excessive bacterial production of H2S in the colon [26]. Moreover, DSS contains a non-absorbable carbohydrate-bound sulfate that can be metabolized to H2S by sulfate-reducing bacteria. However, the hypothesis that endogenous sulfide production by bacterial flora contributes to the pathogenesis of inflammatory bowel disease is controversial. Furne et al. [27] showed that treatment with dextran sulfate did not increase the release of H2S in feces, and scavenging excessive intraluminal H2S using bismuth did not affect the dextran sulfate-induced colitis. However, our data strongly suggest that H2S is produced in the colonic mucosa, although the origin of H2S is not determined.
In our study, colitis severity was assessed by the DAI scores and histology. By each assessment, inhibiting the endogenous H2S-synthesis by PAG significantly deteriorated DSS-induced colitis. Na2S, an H2S donor, negated the effect of PAG. In addition, we showed that PAG treatment significantly increased MPO activity and TBA-reactive substances in DSS-induced inflamed colonic mucosa, and that these increases were significantly negated by co-treatment with Na2S.
Many investigators, including us, have hypothesized that neutrophil-mediated inflammation is involved in the development of DSS-induced colonic mucosal injury. Three lines of evidence support this hypothesis: (1) colonic mucosal endothelial intercellular adhesion molecule 1 (ICAM-1) expression is enhanced at an early stage in the inflammatory cascade of DSS-induced colitis [28]; (2) selective depletion of neutrophils by monoclonal antibody RP-3 suppresses colitis in rats [29]; and (3) immunoneutralization of ICAM-1 on endothelial cells significantly attenuates colonic mucosal injury and neutrophil accumulation in rats [30]. The present study has shown that MPO activity, an index of tissue-associated neutrophil accumulation, significantly increases in the colonic mucosa by inhibiting endogenous H2S generation, and this increase is significantly inhibited by co-treatment with an H2S donor. Histological findings also indicated that inhibiting H2S-synthesis by PAG enhanced leukocyte infiltration and caused severe colitis. These results indicate that the inhibition of neutrophil accumulation by H2S may be one of the protective factors helping to decrease DSS-induced colitis. The inhibitory effect of H2S against neutrophil accumulation is also supported by previous reports, in which H2S inhibited neutrophil-endothelial interaction. Fiorucci et al. [4] showed that H2S suppresses nonsteroidal anti-inflammatory drug-induced gastropathy by suppressing leukocyte adherence via opening K +ATP channels. Zanardo et al. [5] demonstrated that H2S inhibited neutrophil adhesion/activation in carrageenan-induced paw edema.
We showed that PAG significantly enhanced the increase in TBA-reactive substances, an index of lipid peroxidation, in the DSS-induced inflamed colonic mucosa, and this increase was significantly inhibited by supplementing H2S with Na2S. Polyunsaturated fatty acids of cell membranes are degraded by lipid peroxidation, with subsequent disruption of membrane integrity, suggesting that lipid peroxidation mediated by oxygen radicals is an important cause of damage to and destruction of cell membranes [31, 32]. Our data support another recent finding in our laboratory, in which colonic TBA-reactive substances were markedly reduced by treatment with Mn-superoxide dismutase and a synthetic vitamin E analogue in the same DSS colitis mouse model; this suggests that induction of lipid peroxidation is an early critical event in this experimental inflammatory bowel disease model [33]. Although we demonstrated the anti-oxidant activity of H2S in the present study, it was uncertain whether this activity might result from its anti-inflammatory activity or from its direct anti-oxidant activity. Previous reports have demonstrated the cytoprotective effects of H2S, which may be related to the neutralization of various reactive species including oxyradicals [34], peroxynitrite [21], and hypochlorous acid [35]. H2S can also upregulate the endogenous antioxidant system [20].
Our conclusion is that endogenous H2S may act as an anti-inflammatory molecule by preventing neutrophil accumulation and anti-oxidant ability. Further research is needed, because the molecular mechanisms underlying sulfide’s cellular signaling or interactions between H2S and NO/CO are poorly understood.
References
Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6(11):917–935.
Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology. 2006;131(1):259–271.
Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury. Evidence for a role of KATP channels. Basic Res Cardiol. 2006;101(1):53–60.
Fiorucci S, Antonelli E, Distrutti E, et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology. 2005;129(4):1210–1224.
Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006;20(12):2118–2120.
Distrutti E, Sediari L, Mencarelli A, et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther. 2006;316(1):325–335.
Distrutti E, Sediari L, Mencarelli A, et al. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1, 2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther. 2006;319(1):447–458.
Qu K, Chen CPLH, Halliwell B, Moore PK, Wong PTH. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke. 2006;37(3):889–893.
Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J. 2005;19(6):623–625.
Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005;19(9):1196–1198.
Collin M, Anuar FBM, Murch O, Bhatia M, Moore PK, Thiemermann C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol. 2005;146(4):498–505.
Bhatia M, Sidhapuriwala J, Moochhala SM, Moore PK. Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br J Pharmacol. 2005;145(2):141–144.
Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol. 2006;290(6):L1193–L1201.
Oh GS, Pae HO, Lee BS, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med. 2006;41(1):106–119.
Qingyou Z, Junbao D, Weijin Z, Hui Y, Chaoshu T, Chunyu Z. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun. 2004;317(1):30–37.
Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86(2):583–650.
Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 1):177–184. doi:10.1111/j.1365-2036.2004.01992.x.
Takagi T, Naito Y, Inoue M, et al. Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1. Inflammation. 2009;32(2):83–88. doi:10.1007/s10753-009-9106-6.
Takagi T, Naito Y, Mizushima K, et al. Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis. J Gastroenterol Hepatol. 2008;23(Suppl 2):S229–S233. doi:10.1111/j.1440-1746.2008.05443.x.
Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18(10):1165–1167.
Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? J Neurochem. 2004;90(3):765–768.
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238–249.
Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251(4 Pt 1):G567–G574.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
Roediger WE, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci. 1997;42(8):1571–1579.
Furne JK, Suarez FL, Ewing SL, Springfield J, Levitt MD. Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats. Dig Dis Sci. 2000;45(7):1439–1443.
Breider MA, Eppinger M, Gough A. Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats. Vet Pathol. 1997;34(6):598–604.
Natsui M, Kawasaki K, Takizawa H, et al. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol. 1997;12(12):801–808.
Taniguchi T, Tsukada H, Nakamura H, et al. Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats. J Gastroenterol Hepatol. 1998;13(9):945–949.
Niki E, Komuro E. Inhibition of peroxidation of membranes. Basic Life Sci. 1988;49:561–566.
Niki E, Noguchi N, Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans. 1993;21(2):313–317.
Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41(1):18–26. doi:10.3164/jcbn.2007003.
Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004;318(3):756–763.
Whiteman M, Cheung NS, Zhu YZ, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun. 2005;326(4):794–798.
Acknowledgments
This work was supported by a Grant-in-Aid for Scientific Research (B) to T.Y. (no. 21390184) and Challenging Exploratory Research to Y.N. (no. 08101559) from the Japan Society for the Promotion of Science; by a City Area Program to T.Y. and Y.N. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by an Adaptable and Seamless Technology Transfer Program through target-driven R&D to Y.N. from the Japan Science and Technology Agency.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirata, I., Naito, Y., Takagi, T. et al. Endogenous Hydrogen Sulfide Is an Anti-inflammatory Molecule in Dextran Sodium Sulfate-Induced Colitis in Mice. Dig Dis Sci 56, 1379–1386 (2011). https://doi.org/10.1007/s10620-010-1461-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1461-5